PET study of brain acetylcholinesterase in cerebellar degenerative disorders

Movement Disorders

Volumn 23, Issue 8, 2008, Pages 1154-1160

  Hirano, Shigeki ^a,b   Shinotoh, Hitoshi ^b,c   Kimihito, Arai ^d   Aotsuka, Akiyo ^b,e   Yasuno, Fumihiko ^f   Tanaka, Noriko ^b,g   Ota, Tsuneyoshi ^b,h   Sato, Koichi ^b,i   Fukushi, Kiyoshi ^b   Tanada, Shuji ^b   Hattori, Takamichi ^a   Irie, Toshiaki ^b,j  

^a CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

^c Asahi Neurological Hospital   (Japan)

^d SAKURA NATIONAL HOSPITAL   (Japan)

^e Chiba Aoba Municipal Hospital   (Japan)

^f UNIVERSITY OF TSUKUBA HOSPITAL   (Japan)

^g TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^h JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

ⁱ TEIKYO UNIVERSITY CHIBA MEDICAL CENTER   (Japan)

^j National Institute of Radiological Sciences ^*  (Japan)

more..

Author keywords

Acetylcholine; Multiple system atrophy; Positron emission tomography; Spinocerebellar ataxia; Thalamus

Indexed keywords

ACETYLCHOLINESTERASE; CARBON 11; N METHYLPIPERIDIN 4 YL C 11; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BRAIN CORTEX; CEREBELLUM; CEREBELLUM DEGENERATION; CHOLINERGIC ACTIVITY; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HUMAN; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SHY DRAGER SYNDROME; SPINOCEREBELLAR DEGENERATION; THALAMUS; UNIFIED PARKINSON DISEASE RATING SCALE;

ACETYLCHOLINESTERASE; ADULT; AGED; BRAIN; CARBON RADIOISOTOPES; CEREBELLAR CORTEX; CEREBRAL CORTEX; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MACHADO-JOSEPH DISEASE; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SYSTEM ATROPHY; NEUROLOGIC EXAMINATION; PIPERIDINES; POSITRON-EMISSION TOMOGRAPHY; PROPIONATES; SPINOCEREBELLAR ATAXIAS; SPINOCEREBELLAR DEGENERATIONS; THALAMUS;

EID: 52649174219     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.22056     Document Type: Article

References (31)

1. Whitehouse PJ, Price DL, Struble RG, Clark AW, Coyle JT, Delon MR. Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. Science 1982;215:1237-1239.
2. Lee M, Rinne J, Marsden C. The pedunculopontine nucleus: its role in the genesis of movement disorders. Yonsei Med J 2000; 41:167-184.
3. Kish S, Schut L, Simmons J, Gilbert J, Chang L, Rebbetoy M. Brain acetylcholinesterase activity is markedly reduced in dominantly-inherited olivopontocerebellar atrophy. J Neurol Neurosurg Psychiatry 1988;51:544-548.
4. Kish S, Robitaille Y, El-Awar M, et al. Non-Alzheimer-type pattern of brain cholineacetyltransferase reduction in dominantly inherited olivopontocerebellar atrophy. Ann Neurol 1989;26:362-367.
5. Koeppen A, Barron K. The neuropathology of olivopontocerebellar atrophy. In: Duvoisin R, Plaitakis A, editors. The olivopontocerebellar atrophies. New York: Raven Press; 1984. p 13-38.
6. Gilman S, Chervin R, Koeppe R, et al. Obstructive sleep apnea is related to a thalamic cholinergic deficit in MSA. Neurology 2003;61:35-39.
7. Maruyama H, Izumi Y, Morino H, et al. Difference in disease-free survival curve and regional distribution according to subtype of spinocerebellar ataxia: a study of 1,286 Japanese patients. Am J Med Genet 2002;114:578-583.
8. Irie T, Fukushi K, Namba H, et al. Brain acetylcholinesterase activity: validation of a PET tracer in a rat model of Alzheimer's disease. J Nucl Med 1996;37:649-655.
9. Kuhl D, Koeppe R, Minoshima S, et al. In vivo mapping of cerebral acetylcholinesterase activity in aging and Alzheimer's disease. Neurology 1999;52:691-699.
10. 11C]Methylpiperidin-4-yl propionate and positron emission tomography. J Cereb Blood Flow Metab 2004;24: 600-611.
11. Gilman S, Low P, Quinn N, et al. Consensus statement on the diagnosis of multiple system atrophy. J Neurol Sci 1999;163:94-98.
12. Trouillas P, Takayanagi T, Hallett M, et al. International cooperative ataxia rating scale for pharmacological assessment of the cerebellar syndrome. J Neurol Sci 1997;145:205-211.
13. Fahn S, Elton R. The unified parkinson's disease rating scale. In: Fahn S, Marsden C, Calne D, Goldsteins M, editors. Recent development in Parkinson's disease. Florham Park, NJ: Macmillan Healthcare Information; 1987. p 153-163, 293-304.
14. Dubois B, Slachevsky A, Litvan I, Pillon B. The FAB. A frontal assessment battery at bedside. Neurology 2000;55:1621-1626.
15. Folstein M, Folstein S. "Mini-Mental State," a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
16. Yasuno F, Hasnine A, Suhara T, et al. Template-based method for multiple volumes of interest of human brain PET images. NeuroImage 2002;16:577-586.
17. Namba H, Iyo M, Fukushi K, et al. Human cerebral acetylcholinesterase activity measured with positron emission tomography: procedure, normal values and effect of Age. Eur J Nucl Med 1999;26:135-143.
18. Atack JR, Perry EK, Bonham JR, Candy JM, Perry RH. Molecular forms of acetylcholinesterase and butyrylcholinesterase in the aged human central nervous system. J Neurochem 1986;47:263-277.
19. Bohnen NI, Kaufer DI, Ivanco LS, et al. Cortical cholinergic function is more severely affected in parkinsonian dementia than in Alzheimer disease: an in vivo positron emission tomographic study. Arch Neurol 2003;60:1745-1748.
20. Meslum M. Neuroanatomy of cholinesterase in the normal human brain and in Alzheimer's disease. In: Giacobini E, editor. Cholinesterase and cholinesterase inhibitors. London: Martin Dunitz; 2000. p 121-137.
21. Ishikawa A, Yamada M, Makino K, et al. Dementia and delirium in 4 patients with Machado-Joseph disease. Arch Neurol 2002; 59:1804-1808.
22. Berent S, Giordani B, Gilman S, et al. Patterns of neuropsychological performance in multiple system atrophy compared to sporadic and hereditary olivopontocerebellar atrophy. Brain Cogn 2002;50:194-206.
23. Kawai Y, Takeda A, Abe Y, Washimi Y, Tanaka F, Sobue G. Cognitive impairments in Machado-Joseph disease. Arch Neurol 2004;61:1757-1760.
24. Brenneis C, Boesch S, Egger K, et al. Cortical atrophy in the cerebellar variant of multiple system atrophy: a voxel-based morphometry study. Mov Disord 2006;21:159-165.
25. Gilman S, St Laurent R, Koeppe R, Junck L, Kluin K, Lohman M. A comparison of cerebral blood flow and glucose metabolism in olivopontocerebellar atrophy using PET. Neurology 1995;45: 1345-1352.
26. Perani D, Bressi S, Testa D, et al. Clinical/metabolic correlations in multiple system atrophy. A fludeoxyglucose F 18 positron emission tomographic study. Arch Neurol 1995;52:179-185.
27. Benarroch EE, Schmeichel AM, Parisi JE. Depletion of mesopontine cholinergic and sparing of raphe neurons in multiple system atrophy. Neurology 2002;59:944-946.
28. Oakman SA, Faris PL, Cozzari C, Hartman BK. Characterization of the extent of pontomesencephalic cholinergic neurons' projections to the thalamus: comparison with projections to midbrain dopaminergic groups. Neuroscience 1999;94:529-547.
29. Soreq H, Seidman S. Acetylcbolinesterase - new roles for an old actor. Nat Rev Neurosci 2001;2:294-302.
30. Sehested P, Lund H, Kristensen O. Oral choline in cerebellar ataxia. Acta Neurol Scand 1980;62:124-126.
31. Manyam B, Giacobini E, Ferraro T, Hare T. Cerebrospinal fluid as a reflector of central cholinergic and amino acid neurotransmitter activity in cerebellar ataxia. Arch Neurol 1990;47:1194-1199.